Get started
DavidSimpson

Gilead ready for Lift-Off Target1: 123.27 Target2: 140 Stop: 93

Long
Gilead Sciences, Inc. (NASDAQ:GILD)  
DavidSimpson  
NASDAQ:GILD   Gilead Sciences, Inc.
bigpharma drugs Stocks earningswinner
0
0
bigpharma drugs stocks earningswinner
Consistent outperformer with always an Ace up its sleeve. Expect at least a 30% increase in value in 2016. You will never see this stock at these prices ever again. Buy now and thank me Later. All bets are off if we have a financial collapse dragging the share price below 92.96.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.